No Borders Inc. (NBDR) Accesses Lucrative Niche as Big Players Ease Up on CBD Research and Development
The FDA has reiterated its position of not currently allowing the marketing of CBD by adding it to a food or labeling it as a dietary supplement Tight FDA requirements provide an opening for startups like No Borders, Inc., which leverages blockchain supply chain technology to ensure and confirm the quality of CBD products Sales of all legalized cannabis in the U.S. are projected to reach $41 billion in 2025, including $6 billion from hemp-derived CBD products. CBD product sales to consumers to reach an estimated $20 billion by 2024 There is no denying that cannabidiol (CBD) is a booming market…

















